Danshensu-mediated protective effect against hepatic fibrosis induced by carbon tetrachloride in rats.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Pathologie et biologie

• Publication date

  2014-12-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.patbio.2014.07.008PMID 25201143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway.

  2013cited by this paper
• Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.

  2013cited by this paper
• Physiological and Biochemical Basis of Clinical Liver Function Tests: A Review

  2013cited by this paper
• Puerarin mediates hepatoprotection against CCl4-induced hepatic fibrosis rats through attenuation of inflammation response and amelioration of metabolic function.

  2013cited by this paper
• Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.

  2013cited by this paper
• Molecular Pathways Molecular Pathways : JAK / STAT Pathway : Mutations , Inhibitors , and Resistance

  2013cited by this paper
• Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish.

  2013cited by this paper
• Reduced hepatic stellate cell expression of kruppel‐like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury

  2013cited by this paper
• Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation.

  2013cited by this paper
• &agr;-SMA Overexpression Associated With Increased Liver Fibrosis in Infants With Biliary Atresia

  2012cited by this paper
• Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques

  2012cited by this paper
• The synthesis and biological evaluation of novel Danshensu-cysteine analog conjugates as cardiovascular-protective agents.

  2012cited by this paper
• Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.

  2011cited by this paper
• Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve?

  2011cited by this paper
• Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: A narrative review and clinical perspective of prospective data

  2010cited by this paper
• Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.

  2010cited by this paper
• Hepatic stellate cell (vitamin A‐storing cell) and its relative – past, present and future

  2010cited by this paper
• Hepatic stellate cells and liver fibrosis.

  2009cited by this paper
• Liver function test and pregnancy

  2009cited by this paper
• Senescence of activated stellate cells limits liver fibrosis.

  2008cited by this paper
• Liver lipid metabolism.

  2008cited by this paper
• The JAK-STAT Signaling Pathway: Input and Output Integration1

  2007cited by this paper
• Mechanisms of Cell Death in Oxidative Stress

  2007cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180.

  2005cited by this paper
• Epidemiology of liver disease in cystic fibrosis: a longitudinal study.

  2004cited by this paper
• Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems

  2000cited by this paper
• The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

  1999cited by this paper

• The hepatoprotective activity and chemical constituents of Helicteres hirsuta water extract

  2026cites this paper
• Hyperoside attenuates carbon tetrachloride-induced hepatic fibrosis via the poly(ADP-ribose)polymerase-1-high mobility group protein 1 pathway.

  2023cites this paper
• Danshensu attenuated lipopolysaccharide‐induced LX‐2 and T6 cells activation through regulation of ferroptosis

  2022cites this paper
• Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway

  2021cites this paper
• Connective tissue growth factor in hepatocytes is elevated by carbon tetrachloride via STAT3 activation.

  2020cites this paper
• Scoparone alleviates hepatic fibrosis by inhibiting the TLR‐4/NF‐κB pathway

  2020cites this paper
• Potential Mechanisms Underlying the Hepatic-Protective Effects of Danshensu on Iron Overload Mice.

  2020cites this paper
• Bufei Qingyu Granules Inhibit the Development of Systemic Sclerosis via Notch-1/Jagged-2 Signaling Pathway

  2019cites this paper
• Antioxidants in Alzheimer’s Therapy

  2019cites this paper
• Simultaneous quantification of seven constituents from Zaoren Anshen prescription and four endogenic components in rat plasma by UHPLC-TSQ-MS/MS and the application of the correlation study.

  2019cites this paper
• Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling.

  2019cites this paper
• Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis.

  2019cites this paper
• Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids.

  2018cites this paper
• Metabolite identification of tanshinol borneol ester in rats by high-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry.

  2018cites this paper
• San-Cao Granule (三草颗粒) Ameliorates Hepatic Fibrosis through High Mobility Group Box-1 Protein/Smad Signaling Pathway

  2018cites this paper
• Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.

  2017cites this paper
• A network pharmacology approach to discover active compounds and action mechanisms of San-Cao Granule for treatment of liver fibrosis

  2016cites this paper
• Combining an epithelial repair factor and anti‐fibrotic with a corticosteroid offers optimal treatment for allergic airways disease

  2016cites this paper
• Screening for and validation of a hepatic fibrosis-related pathway induced by insulin-like growth factor-binding protein-related protein 1

  2016cites this paper
• Quantitatively metabolic profiles of salvianolic acids in rats after gastric-administration of Salvia miltiorrhiza extract.

  2016cites this paper
• Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca2+ overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats

  2016cites this paper
• Hepatoprotective and Antioxidant Activities of LST-02, A Proprietary Herbal Formulation.

  2015cites this paper
• Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection

  2015cites this paper
• Protective Effect of Infliximab Against Carbon Tetrachloride-Induced Hepatotoxicity.

  2015cites this paper